DYNE THERAPEUTICS INC (DYN) Institutional Shareholders

DYNE THERAPEUTICS INC (DYN) is currently reported in institutional portfolios tracked by InsiderSet based on the latest available SEC Form 13F filings for the quarter ended June 30, 2026. The institutional investors covered on this page collectively reported approximately $3.41B in DYN holdings during the latest filing period.

Blackrock, Inc. is currently the largest disclosed institutional shareholder of DYN tracked by InsiderSet, reporting ownership valued at approximately $275.50M in its June 30, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $324.37M, representing an estimated gain of +17.74% since the filing period.

The top 10 institutional shareholders tracked on this page collectively account for approximately 49% of the total disclosed DYN value among the investors covered in this analysis. Major shareholders include Blackrock, Inc., Fmr Llc, Janus Henderson Group Plc, and several other long-term asset managers with concentrated positions in DYNE THERAPEUTICS INC (DYN).

This page ranks the largest institutional DYN shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.

Institutional Holders

240

Total Reported Value

$3.41B

Largest Holder

Blackrock, Inc.

Largest Position

$275.50M

Insider Transactions (90d)

50

Latest Filing Quarter

Q2 2026

New Institutional Positions

62

Funds Exiting Positions

0

Page 1 of 5
NameInvestor/ManagerPortfolio %QuantityReported BalanceCurrent Estimated ValueGain/loss Since FilingEstimated Portfolio Performance
Blackrock, Inc.0.00%12,404,330$275,500,169$324,373,230+$48,873,061+17.74%
Fmr Llc0.01%11,207,000$248,907,468$293,063,050+$44,155,582+17.74%
Janus Henderson Group Plc0.12%13,647,376$247,426,927$356,878,882+$109,451,955+44.24%
State Street Corp0.00%7,458,263$165,648,021$195,033,577+$29,385,556+17.74%
Orbis Allan Gray Ltd0.53%7,006,542$155,615,298$183,221,073+$27,605,775+17.74%
Atlas Venture Life Science Advisors, Llc17.14%6,800,099$151,030,199$177,822,589+$26,792,390+17.74%
Vanguard Capital Management Llc0.00%6,310,969$140,166,621$165,031,839+$24,865,218+17.74%
Tcg Crossover Management, Llc2.46%4,615,144$102,502,348$120,686,016+$18,183,668+17.74%
Vanguard Portfolio Management Llc0.00%4,048,428$89,915,586$105,866,392+$15,950,806+17.74%
Fcpm Iii Services B.V.11.39%3,848,256$85,469,766$100,631,894+$15,162,128+17.74%
Geode Capital Management, Llc0.00%3,743,427$83,158,757$97,890,616+$14,731,859+17.72%
Vestal Point Capital, Lp1.75%3,375,000$74,958,750$88,256,250+$13,297,500+17.74%
Orbimed Advisors Llc1.36%3,235,684$71,864,542$84,613,137+$12,748,595+17.74%
Frazier Life Sciences Management, L.P.1.53%3,153,082$70,029,951$82,453,094+$12,423,143+17.74%
Armistice Capital, Llc1.90%3,087,226$68,567,289$80,730,960+$12,163,671+17.74%
Jpmorgan Chase & Co0.00%3,151,656$67,154,494$82,415,804+$15,261,310+22.73%
Perceptive Advisors Llc0.93%2,689,235$59,727,909$70,323,495+$10,595,586+17.74%
Logos Global Management Lp2.44%2,550,000$56,635,500$66,682,500+$10,047,000+17.74%
Bank Of America Corp0.00%2,233,398$49,603,770$58,403,358+$8,799,588+17.74%
Venrock Adviser, Llc1.46%2,173,913$48,282,608$56,847,825+$8,565,217+17.74%
Goldman Sachs Group Inc0.01%2,157,195$47,911,301$56,410,649+$8,499,348+17.74%
Siren, L.L.C.0.96%2,129,125$47,287,866$55,676,619+$8,388,753+17.74%
Dimensional Fund Advisors Lp0.01%1,946,479$43,221,836$50,900,426+$7,678,590+17.77%
Mpm Bioimpact Llc2.60%1,922,093$42,689,686$50,262,732+$7,573,046+17.74%
Samlyn Capital, Llc0.65%1,754,708$38,972,065$45,885,614+$6,913,549+17.74%
Sofinnova Investments, Inc.1.97%1,658,384$36,832,709$43,366,742+$6,534,033+17.74%
Palo Alto Investors Lp5.06%1,647,521$36,591,441$43,082,674+$6,491,233+17.74%
Vivo Capital, Llc3.16%1,557,466$34,591,320$40,727,736+$6,136,416+17.74%
Aberdeen Group Plc0.05%1,539,434$34,190,829$40,256,199+$6,065,370+17.74%
Deep Track Capital, Lp0.49%1,500,000$33,315,000$39,225,000+$5,910,000+17.74%
Marshall Wace, Llp0.03%1,488,917$33,068,847$38,935,180+$5,866,333+17.74%
Polar Capital Holdings Plc0.08%1,286,811$28,580,072$33,650,108+$5,070,036+17.74%
Northern Trust Corp0.00%1,278,081$28,386,180$33,421,818+$5,035,638+17.74%
Charles Schwab Investment Management Inc0.00%1,202,203$26,700,929$31,437,608+$4,736,679+17.74%
Sixth Street Partners Management Company, L.P.0.00%1,202,203$26,700,929$31,437,608+$4,736,679+17.74%
Citadel Advisors Llc0.01%1,143,958$25,407,307$29,914,502+$4,507,195+17.74%
Saturn V Capital Management Lp3.37%1,057,493$23,486,920$27,653,442+$4,166,522+17.74%
Vanguard Fiduciary Trust Co0.00%988,949$21,964,557$25,861,016+$3,896,459+17.74%
Novo Holdings A/S1.24%960,394$21,330,351$25,114,303+$3,783,952+17.74%
Rock Springs Capital Management Lp1.02%942,154$20,925,240$24,637,327+$3,712,087+17.74%
Braidwell Lp0.76%921,598$20,468,692$24,099,788+$3,631,096+17.74%
Frontier Capital Management Co Llc0.18%874,138$19,414,605$22,858,709+$3,444,104+17.74%
Baker Bros. Advisors Lp0.09%813,449$18,066,702$21,271,691+$3,204,989+17.74%
Fiera Capital Corp0.06%789,989$17,545,656$20,658,212+$3,112,556+17.74%
Morgan Stanley0.00%746,200$16,573,116$19,513,130+$2,940,014+17.74%
Artisan Partners Limited Partnership0.02%659,786$14,653,847$17,253,404+$2,599,557+17.74%
Raymond James Financial Inc0.00%576,350$12,800,733$15,071,553+$2,270,820+17.74%
Td Asset Management Inc0.01%548,112$12,173,568$14,333,129+$2,159,561+17.74%
Algert Global Llc0.13%506,273$11,244,323$13,239,039+$1,994,716+17.74%
Wasatch Advisors Lp0.06%443,668$9,853,866$11,601,918+$1,748,052+17.74%

Frequently asked questions about DYN

  • Who owns the most DYN stock?

    The largest holders of DYN are typically major institutional investors such as asset managers and hedge funds reporting on Form 13F. The table above ranks tracked superinvestors by reported position size using the latest available filings for DYNE THERAPEUTICS INC (DYN).

  • Is DYN widely held by superinvestors?

    Many widely followed stocks like DYN appear across numerous superinvestor portfolios because of liquidity, index inclusion, and fundamentals. The holder count and table above show how broadly DYN is represented among the institutional managers we track.

  • What do “Current Estimated Value”, “Gain/loss Since Filing”, and “Estimated Portfolio Performance” mean?

    Current Estimated Value is reported share quantity from the latest 13F times our most recent split-adjusted U.S. session close. Gain/loss Since Filing is that estimate minus the reported 13F dollar value; Estimated Portfolio Performance is that difference as a percent of the reported value. Green means the estimate is above the filing value; red means below (not purchase cost). If many filers share the same implied filing price per share, the performance % may match across rows. These are not official fund marks or live quotes.